Neutropenia

Etiology and Pathogenesis

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Neutropenia is defined as an absolute neutrophil count <1500 cells/mm3 and can be graded as mild (1000-1500 cells/mm3), moderate (500-1000 cells/mm3), or severe (<500 cells/mm3). Neutropenia can develop as a result of ≥1 pathologic mechanism, including decreased bone marrow production, the sequestering of neutrophils, and increased destruction of neutrophils in the peripheral blood. The clinical result is increased risk for infection. This risk is directly proportional to the severity and duration of neutropenia. Neutropenia is classified according to the etiology as congenital or acquired, with the latter further defined according to the etiology or pathology. Febrile neutropenia is associated with substantial morbidity and even mortality.

Original languageEnglish (US)
JournalClinical Cornerstone
Volume8
Issue numberSUPPL. 5
StatePublished - Jan 1 2006

Fingerprint

Neutropenia
Neutrophils
Febrile Neutropenia
Bone Marrow
Pathology
Morbidity
Mortality
Infection

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Neutropenia : Etiology and Pathogenesis. / Schwartzberg, Lee.

In: Clinical Cornerstone, Vol. 8, No. SUPPL. 5, 01.01.2006.

Research output: Contribution to journalArticle

@article{8bad7d0b2ad04ae8860104e22a7e2ab0,
title = "Neutropenia: Etiology and Pathogenesis",
abstract = "Neutropenia is defined as an absolute neutrophil count <1500 cells/mm3 and can be graded as mild (1000-1500 cells/mm3), moderate (500-1000 cells/mm3), or severe (<500 cells/mm3). Neutropenia can develop as a result of ≥1 pathologic mechanism, including decreased bone marrow production, the sequestering of neutrophils, and increased destruction of neutrophils in the peripheral blood. The clinical result is increased risk for infection. This risk is directly proportional to the severity and duration of neutropenia. Neutropenia is classified according to the etiology as congenital or acquired, with the latter further defined according to the etiology or pathology. Febrile neutropenia is associated with substantial morbidity and even mortality.",
author = "Lee Schwartzberg",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
volume = "8",
journal = "Clinical Cornerstone",
issn = "1098-3597",
publisher = "Excerpta Medica",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Neutropenia

T2 - Etiology and Pathogenesis

AU - Schwartzberg, Lee

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Neutropenia is defined as an absolute neutrophil count <1500 cells/mm3 and can be graded as mild (1000-1500 cells/mm3), moderate (500-1000 cells/mm3), or severe (<500 cells/mm3). Neutropenia can develop as a result of ≥1 pathologic mechanism, including decreased bone marrow production, the sequestering of neutrophils, and increased destruction of neutrophils in the peripheral blood. The clinical result is increased risk for infection. This risk is directly proportional to the severity and duration of neutropenia. Neutropenia is classified according to the etiology as congenital or acquired, with the latter further defined according to the etiology or pathology. Febrile neutropenia is associated with substantial morbidity and even mortality.

AB - Neutropenia is defined as an absolute neutrophil count <1500 cells/mm3 and can be graded as mild (1000-1500 cells/mm3), moderate (500-1000 cells/mm3), or severe (<500 cells/mm3). Neutropenia can develop as a result of ≥1 pathologic mechanism, including decreased bone marrow production, the sequestering of neutrophils, and increased destruction of neutrophils in the peripheral blood. The clinical result is increased risk for infection. This risk is directly proportional to the severity and duration of neutropenia. Neutropenia is classified according to the etiology as congenital or acquired, with the latter further defined according to the etiology or pathology. Febrile neutropenia is associated with substantial morbidity and even mortality.

UR - http://www.scopus.com/inward/record.url?scp=33947205245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947205245&partnerID=8YFLogxK

M3 - Article

VL - 8

JO - Clinical Cornerstone

JF - Clinical Cornerstone

SN - 1098-3597

IS - SUPPL. 5

ER -